17 ML ferumoxytol 30 MG/ML Injection — RxCUI 860605
RxNorm drug concept · Semantic clinical drug
RxCUI 860605
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI860605
Official name17 ML ferumoxytol 30 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asiron (as ferumoxytol) 510 MG per 17 ML Injection; iron (as ferumoxytol) 510 MG in 17 ML Injection
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)36,883 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ferumoxytol Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Some people can't absorb enough iron from pills, or the pills cause stomach problems like cramping or nausea. If you have chronic kidney disease, oral iron often just doesn't work...
- Why am I getting an IV iron infusion instead of just taking iron pills?
- The infusion is given slowly over at least 15 minutes while you're lying back in a reclined position. After it's done, you'll be observed for at least 30 minutes. The most common t...
- What should I expect during and after my ferumoxytol infusion?
🕸️ Concept Web — How 17 ML ferumoxytol 30 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
17 ML ferumoxytol 30 MG/ML Injection
RxCUI 860605 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ferumoxytol
473387IN
-
Ferumoxytol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Feraheme
854775BN
-
Feraheme
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ferumoxytol Injection
1741130SCDF -
Ferumoxytol Injectable Product
1164420SCDG -
Ferumoxytol Injection [Feraheme]
1741132SBDF -
Feraheme Injectable Product
1167095SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Ferumoxytol Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ferumoxytol 30 MG/ML
860604SCDC -
17 ML ferumoxytol 30 MG/ML Injection [Feraheme]
1191357SBD -
Ferumoxytol 30 MG/ML [Feraheme]
1191356SBDC
-
Ferumoxytol 30 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ferumoxytol 30 MG/ML
SCDC · 860604 -
Ferumoxytol Injection
SCDF · 1741130 -
Ferumoxytol Injectable Product
SCDG · 1164420
Brand-Name Concepts
-
17 ML ferumoxytol 30 MG/ML Injection [Feraheme]
SBD · 1191357 -
Ferumoxytol 30 MG/ML [Feraheme]
SBDC · 1191356 -
Ferumoxytol Injection [Feraheme]
SBDF · 1741132 -
Feraheme Injectable Product
SBDG · 1167095 -
Feraheme
BN · 854775
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 860605 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00781-3154-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3154-01) / 17 mL in 1... | Ferumoxytol | Sandoz Inc | 2021-07-15 |
| 00781-3154-95 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3154-95) / 17 mL in... | Ferumoxytol | Sandoz Inc | 2021-07-15 |
| 59338-0775-01 | 1 VIAL, SINGLE-USE in 1 CARTON (59338-775-01) / 17 mL in 1... | Feraheme | AMAG Pharmaceuticals, Inc | 2009-07-13 |
| 59338-0775-10 | 10 VIAL, SINGLE-USE in 1 CARTON (59338-775-10) / 17 mL in 1... | Feraheme | AMAG Pharmaceuticals, Inc | 2009-07-13 |
Observed labelers:
AMAG Pharmaceuticals, Inc (2) ·
Sandoz Inc (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| Q0138 | Ferumoxytol, non-esrd | 2 | CMS |
| Q0139 | Ferumoxytol, esrd use | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.